After SII, Bharat Biotech reduces Covaxin price; 400 per dose for state govts

PUBLISHED ON APR 29, 2021 07:23 PM IST
About The Video

  • Bharat Biotech on Thursday announced a cut in price of its COVID-19 vaccine 'Covaxin' it plans to sell to the states to 400 per dose from the earlier 600. This follows a widespread criticism of its pricing policy as it sold Covaxin to the central government at 150 per dose. "Recognising the enormous challenges in the public healthcare system, we have made Covaxin available to state governments at a price of 400/ dose", Bharat Biotech said in its announcement. Watch the full video for more details.


Story Saved